Shares of The Biotech Growth Trust PLC (LON:BIOG – Get Free Report) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 898.04 ($11.07) and traded as low as GBX 832 ($10.26). The Biotech Growth Trust shares last traded at GBX 832 ($10.26), with a volume of 27,991 shares trading hands.
The Biotech Growth Trust Price Performance
The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00. The firm has a fifty day moving average of GBX 898.04 and a two-hundred day moving average of GBX 977.63. The stock has a market capitalization of £267.84 million, a P/E ratio of 402.71 and a beta of 0.50.
Insider Activity at The Biotech Growth Trust
In other news, insider Nicola Shepherd bought 1,000 shares of The Biotech Growth Trust stock in a transaction on Monday, January 13th. The stock was acquired at an average cost of GBX 846 ($10.43) per share, for a total transaction of £8,460 ($10,431.57). Also, insider Hamish Baillie bought 3,000 shares of The Biotech Growth Trust stock in a transaction on Wednesday, November 27th. The stock was purchased at an average price of GBX 931 ($11.48) per share, with a total value of £27,930 ($34,438.96). Insiders bought 6,222 shares of company stock worth $5,659,584 over the last three months. 0.71% of the stock is owned by corporate insiders.
The Biotech Growth Trust Company Profile
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Read More
- Five stocks we like better than The Biotech Growth Trust
- What is a Death Cross in Stocks?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Bank Stocks – Best Bank Stocks to Invest In
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- 3 Stocks to Consider Buying in October
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.